AMRI and Parnell Manufacturing Pty Ltd. have entered into a development and commercial supply agreement, under which AMRI will provide process development, manufacturing and supply of APIs to support Parnell’s New Animal Drug Application (NADA) with the FDA, as well as the commercial launch of the veterinary product in the U.S., pending approval. Development and manufacture of the API will take place at AMRI’s facilities in Albany, NY. “We are pleased to support Parnell in its introduction o...